1. Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment
   Zhaoyun Liu et al, 2021, Frontiers in Oncology CrossRef
2. A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
   Tianyu Zeng et al, 2022, Cancers CrossRef
3. A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer
   Jia-Yi Huang et al, 2023, Frontiers in Oncology CrossRef
4. Efficacy and safety of apatinib combined with dose‐dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis
   Jiaxuan Liu et al, 2024, International Journal of Cancer CrossRef
5. Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting
   Ruyan Zhang et al, 2023, Frontiers in Oncology CrossRef